Status: Recruiting
Clofutriben Pharmacokinetics in Patients With Impaired Renal Function
This is a Phase 1, single-center, open-label, single-dose trial. Sixteen participants are planned: 8 participants with moderate renal impairment and 8 matched control participants with normal renal function.
Participants needed: 16
Trial details
Phase: Phase 1Age: 18-83Biological sex: AllType: InterventionalSponsor: Sparrow PharmaceuticalsUpdated: Dec 23, 2025Locations: 1
Eligibility criteria
Male and female participants with stable moderate renal impairment (estimated gl...
Participant whose current or recent medical conditions, medications, or procedur...